GATAD1 is a chr7-associated transcription factor containing a GATA zinc finger domain that functions as a component of chr7 complexes recruited to H3K4me3-marked histone sites 1. Its primary mechanism involves epigenetic regulation through histone modification and chr7 architecture remodeling. GATAD1 represses transcription of developmental genes like KISS1 and TAC3 by recruiting histone demethylase KDM1A to reduce activating H3K4me2 marks 1. In cancer contexts, GATAD1 promotes proliferation by inducing long-range chr7 interactions at the CCND1 promoter in gliomas 2 and regulates SRRM2 expression in thyroid carcinoma recurrence 3. Clinically, GATAD1 is most significantly associated with dilated cardiomyopathy (DCM), where homozygous mutations cause autosomal recessive disease with aberrant nuclear localization and subcellular expression patterns in ventricular myocytes 4. A specific serine phosphorylation site mutation in GATAD1 causes DCM by disrupting 14-3-3 protein binding, which normally regulates nucleocytoplasmic transport via masking a nuclear localization signal 5. Adult zebrafish models confirm that GATAD1 mutations induce heart failure phenotypes under stress conditions 6. Additionally, GATAD1 shows reduced expression in preeclamptic placentas with altered DNA methylation patterns 7, and elevated expression correlates with poor prognosis in gliomas and thyroid cancer.